Skip to main content
Top
Published in: Breast Cancer Research and Treatment 1/2009

01-11-2009 | Preclinical Study

Risk factors for breast cancer from benign breast disease in a diverse population

Authors: Maria J. Worsham, Usha Raju, Mei Lu, Alissa Kapke, Alyssa Botttrell, Jingfang Cheng, Varsha Shah, Adnan Savera, Sandra R. Wolman

Published in: Breast Cancer Research and Treatment | Issue 1/2009

Login to get access

Abstract

Background The majority of studies have reported risks of breast cancer (BC) from benign breast disease (BBD) in essentially homogenous Caucasian populations. Information on breast cancer risk factors in larger, multi-ethnic populations should facilitate the development of appropriate and targeted risk reduction strategies. Design Cases and controls were drawn from a parent BBD cohort of 4,970 women, 1,341 African–Americans (AA) and 3,629 non-AA who were diagnosed with BBD after examination of an excisional breast biopsy. Risk factors (34 variables) included demographics, lesion types, and epidemiological variables. Results The final multivariable model retained significance (P < 0.05) for lesion risk-level, fibroadenoma, and the interaction of age-by-race. Women with proliferative lesions (no atypia, risk level 2) were 1.7 times more likely to develop BC when compared with women with non-proliferative lesions (OR = 1.7, 95% CI 1.13, 2.42, P = 0.009). Women with atypia (risk level 3) were 3.75 times more likely to develop BC compared to women with non-proliferative lesions (OR = 3.75, 95% CI 1.99, 7.06, P < 0.001). The odds of breast cancer was approximately 35% lower among women with fibroadenoma as compared to women without fibroadenoma (OR = 0.65, 95% CI 0.46, 0.94, P = 0.020). AA women with BBD who were 50 years or older were 2.28 times more likely to develop breast cancer as compared to non-AA women who were less than 50 years old (OR = 2.28, 95% CI 1.34, 3.88, P = 0.002). Conclusion Women with fibroadenoma (nonproliferative or proliferative) were less likely to progress to BC. Older AA women are at greater risk for progression to breast cancer from BBD.
Appendix
Available only for authorised users
Literature
2.
go back to reference Hartmann LC, Sellers TA, Frost MH, Lingle WL, Degnim AC, Ghosh K, Vierkant RA, Maloney SD, Pankratz VS, Hillman DW, Suman VJ, Johnson J, Blake C, Tlsty T, Vachon CM, Melton LJIII, Visscher DW (2005) Benign breast disease and the risk of breast cancer. N Engl J Med 353:229–237. doi:10.1056/NEJMoa044383 CrossRefPubMed Hartmann LC, Sellers TA, Frost MH, Lingle WL, Degnim AC, Ghosh K, Vierkant RA, Maloney SD, Pankratz VS, Hillman DW, Suman VJ, Johnson J, Blake C, Tlsty T, Vachon CM, Melton LJIII, Visscher DW (2005) Benign breast disease and the risk of breast cancer. N Engl J Med 353:229–237. doi:10.​1056/​NEJMoa044383 CrossRefPubMed
5.
go back to reference Marshall LM, Hunter DJ, Connolly JL, Schnitt SJ, Byrne C, London SJ, Colditz GA (1997) Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types. Cancer Epidemiol Biomarkers Prev 6:297–301PubMed Marshall LM, Hunter DJ, Connolly JL, Schnitt SJ, Byrne C, London SJ, Colditz GA (1997) Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types. Cancer Epidemiol Biomarkers Prev 6:297–301PubMed
6.
go back to reference Newman LA, Griffith KA, Jatoi I, Simon MS, Crowe JP, Colditz GA (2006) Meta-analysis of survival in African American and white American patients with breast cancer: ethnicity compared with socioeconomic status. J Clin Oncol 24:1342–1349. doi:10.1200/JCO.2005.03.3472 CrossRefPubMed Newman LA, Griffith KA, Jatoi I, Simon MS, Crowe JP, Colditz GA (2006) Meta-analysis of survival in African American and white American patients with breast cancer: ethnicity compared with socioeconomic status. J Clin Oncol 24:1342–1349. doi:10.​1200/​JCO.​2005.​03.​3472 CrossRefPubMed
7.
go back to reference Ghafoor A, Jemal A, Ward E, Cokkinides V, Smith R, Thun M (2003) Trends in breast cancer by race and ethnicity. CA Cancer J Clin 53:342–355CrossRefPubMed Ghafoor A, Jemal A, Ward E, Cokkinides V, Smith R, Thun M (2003) Trends in breast cancer by race and ethnicity. CA Cancer J Clin 53:342–355CrossRefPubMed
8.
go back to reference Sanders ME, Page DL, Simpson JF, Schuyler PA, Dale Plummer W, Dupont WD (2006) Interdependence of radial scar and proliferative disease with respect to invasive breast carcinoma risk in patients with benign breast biopsies. Cancer 106:1453–1461. doi:10.1002/cncr.21730 CrossRefPubMed Sanders ME, Page DL, Simpson JF, Schuyler PA, Dale Plummer W, Dupont WD (2006) Interdependence of radial scar and proliferative disease with respect to invasive breast carcinoma risk in patients with benign breast biopsies. Cancer 106:1453–1461. doi:10.​1002/​cncr.​21730 CrossRefPubMed
9.
go back to reference Degnim AC, Visscher DW, Berman HK, Frost MH, Sellers TA, Vierkant RA, Maloney SD, Pankratz VS, de Groen PC, Lingle WL, Ghosh K, Penheiter L, Tlsty T, Melton LJIII, Reynolds CA, Hartmann LC (2007) Stratification of breast cancer risk in women with atypia: a Mayo cohort study. J Clin Oncol 25:2671–2677. doi:10.1200/JCO.2006.09.0217 CrossRefPubMed Degnim AC, Visscher DW, Berman HK, Frost MH, Sellers TA, Vierkant RA, Maloney SD, Pankratz VS, de Groen PC, Lingle WL, Ghosh K, Penheiter L, Tlsty T, Melton LJIII, Reynolds CA, Hartmann LC (2007) Stratification of breast cancer risk in women with atypia: a Mayo cohort study. J Clin Oncol 25:2671–2677. doi:10.​1200/​JCO.​2006.​09.​0217 CrossRefPubMed
10.
go back to reference Dupont WD, Page DL (1985) Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 312:146–151PubMed Dupont WD, Page DL (1985) Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 312:146–151PubMed
11.
go back to reference Krieger N, Hiatt RA (1992) Risk of breast cancer after benign breast diseases. Variation by histologic type, degree of atypia, age at biopsy, and length of follow-up. Am J Epidemiol 135:619–631PubMed Krieger N, Hiatt RA (1992) Risk of breast cancer after benign breast diseases. Variation by histologic type, degree of atypia, age at biopsy, and length of follow-up. Am J Epidemiol 135:619–631PubMed
12.
go back to reference Carter CL, Corle DK, Micozzi MS, Schatzkin A, Taylor PR (1988) A prospective study of the development of breast cancer in 16,692 women with benign breast disease. Am J Epidemiol 128:467–477PubMed Carter CL, Corle DK, Micozzi MS, Schatzkin A, Taylor PR (1988) A prospective study of the development of breast cancer in 16,692 women with benign breast disease. Am J Epidemiol 128:467–477PubMed
14.
go back to reference Dupont WD, Parl FF, Hartmann WH, Brinton LA, Winfield AC, Worrell JA, Schuyler PA, Plummer WD (1993) Breast cancer risk associated with proliferative breast disease and atypical hyperplasia. Cancer 71:1258–1265. doi:10.1002/1097-0142(19930215)71:4<1258::AID-CNCR2820710415>3.0.CO;2-I Dupont WD, Parl FF, Hartmann WH, Brinton LA, Winfield AC, Worrell JA, Schuyler PA, Plummer WD (1993) Breast cancer risk associated with proliferative breast disease and atypical hyperplasia. Cancer 71:1258–1265. doi:10.1002/1097-0142(19930215)71:4<1258::AID-CNCR2820710415>3.0.CO;2-I
15.
go back to reference Dupont WD, Page DL, Parl FF, Plummer WD Jr, Schuyler PA, Kasami M, Jensen RA (1999) Estrogen replacement therapy in women with a history of proliferative breast disease. Cancer 85:1277–1283. doi:10.1002/(SICI)1097-0142(19990315)85:6<1277::AID-CNCR9>3.0.CO;2-E Dupont WD, Page DL, Parl FF, Plummer WD Jr, Schuyler PA, Kasami M, Jensen RA (1999) Estrogen replacement therapy in women with a history of proliferative breast disease. Cancer 85:1277–1283. doi:10.1002/(SICI)1097-0142(19990315)85:6<1277::AID-CNCR9>3.0.CO;2-E
20.
go back to reference Tamimi RM, Byrne C, Baer HJ, Rosner B, Schnitt SJ, Connolly JL, Colditz GA (2005) Benign breast disease, recent alcohol consumption, and risk of breast cancer: a nested case—control study. Breast Cancer Res 7:R555–R562. doi:10.1186/bcr1039 CrossRefPubMed Tamimi RM, Byrne C, Baer HJ, Rosner B, Schnitt SJ, Connolly JL, Colditz GA (2005) Benign breast disease, recent alcohol consumption, and risk of breast cancer: a nested case—control study. Breast Cancer Res 7:R555–R562. doi:10.​1186/​bcr1039 CrossRefPubMed
21.
go back to reference Cowan DF (1989) H. T. Involution of the breast in women aged 50 to 104 years: a histopathological study of 102 cases. Surg Pathol 2:323–333 Cowan DF (1989) H. T. Involution of the breast in women aged 50 to 104 years: a histopathological study of 102 cases. Surg Pathol 2:323–333
23.
go back to reference Milanese TR, Hartmann LC, Sellers TA, Frost MH, Vierkant RA, Maloney SD, Pankratz VS, Degnim AC, Vachon CM, Reynolds CA, Thompson RA, Melton LJIII, Goode EL, Visscher DW (2006) Age-related lobular involution and risk of breast cancer. J Natl Cancer Inst 98:1600–1607PubMedCrossRef Milanese TR, Hartmann LC, Sellers TA, Frost MH, Vierkant RA, Maloney SD, Pankratz VS, Degnim AC, Vachon CM, Reynolds CA, Thompson RA, Melton LJIII, Goode EL, Visscher DW (2006) Age-related lobular involution and risk of breast cancer. J Natl Cancer Inst 98:1600–1607PubMedCrossRef
24.
go back to reference Henson DE, Tarone RE (1994) Involution and the etiology of breast cancer. Cancer 74:424–429. doi:10.1002/1097-0142(19941001)74:7<1974::AID-CNCR2820740724>3.0.CO;2-0 Henson DE, Tarone RE (1994) Involution and the etiology of breast cancer. Cancer 74:424–429. doi:10.1002/1097-0142(19941001)74:7<1974::AID-CNCR2820740724>3.0.CO;2-0
27.
go back to reference Markopoulos C, Kouskos E, Mantas D, Kontzoglou K, Antonopoulou K, Revenas Z, Kyriakou V (2004) Fibroadenomas of the breast: is there any association with breast cancer? Eur J Gynaecol Oncol 25:495–497PubMed Markopoulos C, Kouskos E, Mantas D, Kontzoglou K, Antonopoulou K, Revenas Z, Kyriakou V (2004) Fibroadenomas of the breast: is there any association with breast cancer? Eur J Gynaecol Oncol 25:495–497PubMed
29.
go back to reference McDivitt RW, Stevens JA, Lee NC, Wingo PA, Rubin GL, Gersell D (1992) Histologic types of benign breast disease and the risk for breast cancer. The cancer and steroid hormone study group. Cancer 69:1408–1414. doi:10.1002/1097-0142(19920315)69:6<1408::AID-CNCR2820690617>3.0.CO;2-C McDivitt RW, Stevens JA, Lee NC, Wingo PA, Rubin GL, Gersell D (1992) Histologic types of benign breast disease and the risk for breast cancer. The cancer and steroid hormone study group. Cancer 69:1408–1414. doi:10.1002/1097-0142(19920315)69:6<1408::AID-CNCR2820690617>3.0.CO;2-C
32.
35.
go back to reference Thomas DB, Persing JP, Hutchinson WB (1982) Exogenous estrogens and other risk factors for breast cancer in women with benign breast diseases. J Natl Cancer Inst 69:1017–1025PubMed Thomas DB, Persing JP, Hutchinson WB (1982) Exogenous estrogens and other risk factors for breast cancer in women with benign breast diseases. J Natl Cancer Inst 69:1017–1025PubMed
36.
go back to reference Dupont WD, Page DL, Rogers LW, Parl FF (1989) Influence of exogenous estrogens, proliferative breast disease, and other variables on breast cancer risk. Cancer 63:948–957. doi:10.1002/1097-0142(19890301)63:5<948::AID-CNCR2820630527>3.0.CO;2-U Dupont WD, Page DL, Rogers LW, Parl FF (1989) Influence of exogenous estrogens, proliferative breast disease, and other variables on breast cancer risk. Cancer 63:948–957. doi:10.1002/1097-0142(19890301)63:5<948::AID-CNCR2820630527>3.0.CO;2-U
37.
go back to reference Byrne C, Connolly JL, Colditz GA, Schnitt SJ (2000) Biopsy confirmed benign breast disease, postmenopausal use of exogenous female hormones, and breast carcinoma risk. Cancer 89:2046–2052. doi:10.1002/1097-0142(20001115)89:10<2046::AID-CNCR3>3.0.CO;2-F Byrne C, Connolly JL, Colditz GA, Schnitt SJ (2000) Biopsy confirmed benign breast disease, postmenopausal use of exogenous female hormones, and breast carcinoma risk. Cancer 89:2046–2052. doi:10.1002/1097-0142(20001115)89:10<2046::AID-CNCR3>3.0.CO;2-F
38.
go back to reference Rosenberg L, Miller DR, Helmrich SP, Kaufman DW, Schottenfeld D, Stolley PD, Shapiro S (1985) Breast cancer and the consumption of coffee. Am J Epidemiol 122:391–399PubMed Rosenberg L, Miller DR, Helmrich SP, Kaufman DW, Schottenfeld D, Stolley PD, Shapiro S (1985) Breast cancer and the consumption of coffee. Am J Epidemiol 122:391–399PubMed
Metadata
Title
Risk factors for breast cancer from benign breast disease in a diverse population
Authors
Maria J. Worsham
Usha Raju
Mei Lu
Alissa Kapke
Alyssa Botttrell
Jingfang Cheng
Varsha Shah
Adnan Savera
Sandra R. Wolman
Publication date
01-11-2009
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 1/2009
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-008-0198-8

Other articles of this Issue 1/2009

Breast Cancer Research and Treatment 1/2009 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine